reference/3954621

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3954621

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	512
issn	1532-1827 0007-0920
issueIdentifier	4
pageRange	503-512
publicationName	British Journal of Cancer
startingPage	503
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d29184df8844e34b460482b1b6dbad96 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7443cfbca2d10bca76ef7490332f9ae6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_071dad1aec4d7490839b6678bcec8ff0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_02c869022ec749a53500b86dc3c3a6de http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_88108ce2c0d769182c5e0bd44310b6c7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_17fa685d8a4c740c0a14117be1f504ff http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_62591d0a2dd2c5f64d8f9549e3956286
bibliographicCitation	Pirovano G, Ashton TM, Herbert KJ, Bryant RJ, Verrill CL, Cerundolo L, Buffa FM, Prevo R, Harrap I, Ryan AJ, Macaulay V, McKenna WG, Higgins GS. TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy. British Journal of Cancer. 2017 Jul 04;117(4):503–12. doi: 10.1038/bjc.2017.197.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09a7fd52c2eb57acb666f02f9b3085af http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fee67b29a152a01d9a176dcc28f682ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b110d17afe020efcc92eb337a9499fa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5a30c7139cb12a64821eb5055886b9d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b31c0d86510e92db1cffb0829ca1929 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8862-3613 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_492347bc196d37267527799a525becd6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_361e7b2e9aab993db1ddb25ad0c488b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7039a57465590d11f966619dfb1adfc3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a694c5175d8e4d70d477553459da912e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca87a90978c4c2cc4f89bafe6b1c0417 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_439f822d0adc1f7f31766e05c93dc718 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee94a7d58fc920ce4e2f1214d9436297 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6241-7969 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1adf3a190552b08930e7f65bbf94638
date	2017-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/28677687 https://pubmed.ncbi.nlm.nih.gov/PMC5558685 https://doi.org/10.1038/bjc.2017.197
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765 https://portal.issn.org/resource/ISSN/1532-1827 https://portal.issn.org/resource/ISSN/0007-0920
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy
discusses	http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0328038 http://id.nlm.nih.gov/mesh/M0363871 http://id.nlm.nih.gov/mesh/M000635844 http://id.nlm.nih.gov/mesh/M0023650
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ae6e03cbecb7de45c19d24596aa66cd1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67448186 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89675898 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.12.2 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.13.3 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131709236 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7277

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID55872

Total number of triples: 61.